Published in J Neurosurg on September 01, 1984
Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis. Neurosurg Rev (2010) 1.69
Syringomyelia and arachnoiditis. J Neurol Neurosurg Psychiatry (1990) 1.33
International survey on the management of Chiari I malformation and syringomyelia. Childs Nerv Syst (2004) 1.23
Syringoperitoneal shunt for treatment of cord cavitation. J Neurol Neurosurg Psychiatry (1985) 1.06
Incidence, management, and outcome of post-traumatic syringomyelia. In memory of Mr Bernard Williams. J Neurol Neurosurg Psychiatry (1996) 0.87
Posttraumatic syringomyelia. West J Med (1988) 0.83
Syringo-subarachnoid-peritoneal shunt using T-tube for treatment of post-traumatic syringomyelia. J Korean Neurosurg Soc (2012) 0.80
MRI measurement of syrinx size before and after operation. J Neurol Neurosurg Psychiatry (1987) 0.79
Effects of surgery on the sensory deficits of syringomyelia and predictors of outcome: a long term prospective study. J Neurol Neurosurg Psychiatry (2004) 0.77
Hydromyelia: a critical review. Childs Nerv Syst (1988) 0.77
Syringomyelia associated with spinal arachnoiditis treated by partial arachnoid dissection and syrinx-far distal subarachnoid shunt. Clin Med Insights Case Rep (2014) 0.77
Focal adhesive arachnoiditis of the spinal cord: Imaging diagnosis and surgical resolution. J Craniovertebr Junction Spine (2010) 0.77
Long-term result of the Echols procedure for treating syringomyelia. J Neurosurg Spine (2009) 0.75
Syringosubarachnoid shunting using a myringotomy tube. Surg Neurol Int (2016) 0.75
Intracranial hypotension after syringopleural shunting in posttraumatic syringomyelia: Case report and review of the literature. Asian J Neurosurg (2015) 0.75
Delamination technique together with longitudinal incisions for treatment of Chiari I/syringomyelia complex: a prospective clinical study. Cerebrospinal Fluid Res (2009) 0.75
Difficult-to-wean: High index of suspicion. Am J Case Rep (2014) 0.75
Shunting of recurrent post-traumatic syringomyelia into the fourth ventricle: a case report. J Med Case Rep (2010) 0.75
Treatment of Posttubercular Syringomyelia Not Responsive to Antitubercular Therapy: Case Report and Review of Literature. J Neurol Surg Rep (2017) 0.75
Neurosurgery: diagnosis and surgical management of cervical syringomyelia. West J Med (1986) 0.75
A new technique of placing the peritoneal end of syringoperitoneal shunt. Childs Nerv Syst (2014) 0.75
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
High gamma power is phase-locked to theta oscillations in human neocortex. Science (2006) 10.40
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A (2000) 9.67
A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity (2001) 9.45
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature (1999) 8.50
The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06
An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87
Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens. J Exp Med (1980) 5.23
Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA (1998) 4.94
Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol (1995) 4.92
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg (1978) 4.55
Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol (2001) 3.89
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Continuous and discontinuous protein antigenic determinants. Nature (1986) 3.26
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics (1980) 3.21
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med (1988) 3.14
Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int (1973) 3.09
Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome. Lancet (1976) 3.00
Diagnosis and management of pituitary abscess: a review of twenty-four cases. J Neurosurg (2001) 3.00
Epilepsy surgery trends in the United States, 1990-2008. Neurology (2012) 2.97
Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol (2001) 2.86
DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J Neurosci (2001) 2.75
Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63
Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med (1974) 2.51
Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol (1988) 2.47
Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest (1981) 2.41
Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein. J Virol (1993) 2.40
Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg (1977) 2.39
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol (2001) 2.34
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J (1986) 2.22
Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med (1974) 2.20
Endovascular and surgical treatment of unruptured cerebral aneurysms: comparison of risks. Ann Neurol (2000) 2.20
Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol (1998) 2.11
Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. Neurosurgery (1993) 2.10
Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08
Diagnosis of immunopathologic renal disease. Kidney Int (1974) 2.07
Meningiomas induced by high-dose cranial irradiation. J Neurosurg (1993) 2.05
Use of intrathecally administered morphine in the treatment of postoperative pain after lumbar spinal surgery: a prospective, double-blind, placebo-controlled study. Neurosurgery (1991) 2.05
Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest (1986) 2.05
In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. Cancer Res (1976) 2.04
Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet (1995) 2.03
Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg (1994) 2.00
An evaluation of elution techniques in the study of immune complex glomerulonephritis. J Immunol (1977) 1.96
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
Antigen quantitation in experimental immune complex glomerulonephritis. I. Acute serum sickness. J Immunol (1970) 1.93
Normal perfusion pressure breakthrough theory. Clin Neurosurg (1978) 1.87
Epidermoid cysts of the posterior fossa. J Neurosurg (1985) 1.85
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions. Neurosurgery (2000) 1.83
Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis (1988) 1.82
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep (1983) 1.81
Skull base and calvarial deformities: association with intracranial changes in craniofacial syndromes. AJNR Am J Neuroradiol (1996) 1.81
Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J (1987) 1.80
Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int (1987) 1.78
Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77
T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol (2000) 1.76
Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J Exp Med (1986) 1.75
Quantitation of acute and chronic serum sickness in the rabbit. J Exp Med (1971) 1.74
Revised classification of posterior fossa cysts and cystlike malformations based on the results of multiplanar MR imaging. AJR Am J Roentgenol (1989) 1.74
The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg (1990) 1.72
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J Virol (1996) 1.70
Current multimodality management of infectious intracranial aneurysms. Neurosurgery (2001) 1.68
Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg (1994) 1.68
Restricted production of interleukin 4 by activated human T cells. Proc Natl Acad Sci U S A (1988) 1.67
Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int (1977) 1.66
Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery (1998) 1.66
Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest (1995) 1.65
Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest (1991) 1.64
Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J Clin Invest (1982) 1.64
Activity of human blood leukocytes against Toxoplasma gondii. J Infect Dis (1979) 1.63
Iron deficiency and glycosylated haemoglobin A. Lancet (1980) 1.62
Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest (1995) 1.62
Interventional neuroradiological management of vein of Galen malformations in the neonate. Neurosurgery (1990) 1.62
Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61
Susceptibility of Legionella pneumophila to oxygen-dependent microbicidal systems. J Immunol (1982) 1.61
Neuroepithelial cysts of the posterior fossa. Case report. J Neurosurg (1990) 1.60
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med (1987) 1.59
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. Int J Radiat Oncol Biol Phys (1991) 1.59
Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys (1993) 1.59
Slow-flow vascular malformations of the pons: capillary telangiectasias? AJNR Am J Neuroradiol (1996) 1.58
Intracellular penetration and antimicrobial activity of antibiotics. J Antimicrob Chemother (1983) 1.58
First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys (1990) 1.57
Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age. Surg Gynecol Obstet (1993) 1.57
Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J Exp Med (1993) 1.57
Development of acquired arteriovenous fistulas in rats due to venous hypertension. J Neurosurg (1994) 1.56
Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys (1996) 1.56